DK1124842T3 - Betulinsyrederivater anvendelige til behandling af neuroektodermale tumorer - Google Patents

Betulinsyrederivater anvendelige til behandling af neuroektodermale tumorer

Info

Publication number: DK1124842T3
Authority: DK; Denmark
Prior art keywords: treatment; neuroectodermal tumors; betulinic acid; acid derivatives; derivatives useful
Prior art date: 1998-10-28

Application number

DK99955899T

Other languages

English (en)

Inventor

Klaus Michael Debatin

Simone Fulda

Manfred Wiessler

Marek Los

Walter Mier

Original Assignee

Deutsches Krebsforsch

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-10-28

Filing date

1999-10-28

Publication date

2003-09-22

1999-10-28 Application filed by Deutsches Krebsforsch filed Critical Deutsches Krebsforsch

2003-09-22 Application granted granted Critical

2003-09-22 Publication of DK1124842T3 publication Critical patent/DK1124842T3/da

Links

208000009277 Neuroectodermal Tumors Diseases 0.000 title abstract 5
QGJZLNKBHJESQX-FZFNOLFKSA-N betulinic acid Chemical class C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C(=C)C)[C@@H]5[C@H]4CC[C@@H]3[C@]21C QGJZLNKBHJESQX-FZFNOLFKSA-N 0.000 title abstract 4
QGJZLNKBHJESQX-UHFFFAOYSA-N 3-Epi-Betulin-Saeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C(=C)C)C5C4CCC3C21C QGJZLNKBHJESQX-UHFFFAOYSA-N 0.000 abstract 3
CLOUCVRNYSHRCF-UHFFFAOYSA-N 3beta-Hydroxy-20(29)-Lupen-3,27-oic acid Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C(O)=O)CCC5(C)CCC(C(=C)C)C5C4CCC3C21C CLOUCVRNYSHRCF-UHFFFAOYSA-N 0.000 abstract 3
DIZWSDNSTNAYHK-XGWVBXMLSA-N Betulinic acid Natural products CC(=C)[C@@H]1C[C@H]([C@H]2CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@@]34C)[C@@H]12)C(=O)O DIZWSDNSTNAYHK-XGWVBXMLSA-N 0.000 abstract 3
PZXJOHSZQAEJFE-UHFFFAOYSA-N dihydrobetulinic acid Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C(C)C)C5C4CCC3C21C PZXJOHSZQAEJFE-UHFFFAOYSA-N 0.000 abstract 3
MQYXUWHLBZFQQO-UHFFFAOYSA-N nepehinol Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C)CCC(C(=C)C)C5C4CCC3C21C MQYXUWHLBZFQQO-UHFFFAOYSA-N 0.000 abstract 3
239000003795 chemical substances by application Substances 0.000 abstract 2
150000001875 compounds Chemical class 0.000 abstract 2
230000000973 chemotherapeutic effect Effects 0.000 abstract 1
230000010534 mechanism of action Effects 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1
230000003389 potentiating effect Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J63/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
- C07J63/008—Expansion of ring D by one atom, e.g. D homo steroids

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Epidemiology (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Steroid Compounds (AREA)
Medicines Containing Plant Substances (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

DK99955899T 1998-10-28 1999-10-28 Betulinsyrederivater anvendelige til behandling af neuroektodermale tumorer DK1124842T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US09/182,588 US6369109B1 (en)	1998-10-28	1998-10-28	Betulinic acid and derivatives thereof useful for the treatment of neuroectodermal tumor
PCT/EP1999/008196 WO2000024762A1 (en)	1998-10-28	1999-10-28	Betulinic acid and derivatives thereof useful for the treatment of neuroectodermal tumors

Publications (1)

Publication Number	Publication Date
DK1124842T3 true DK1124842T3 (da)	2003-09-22

Family

ID=22669114

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK99955899T DK1124842T3 (da)	1998-10-28	1999-10-28	Betulinsyrederivater anvendelige til behandling af neuroektodermale tumorer

Country Status (9)

Country	Link
US (1)	US6369109B1 (da)
EP (1)	EP1124842B1 (da)
AT (1)	ATE241641T1 (da)
AU (1)	AU1266900A (da)
DE (1)	DE69908397T2 (da)
DK (1)	DK1124842T3 (da)
ES (1)	ES2201800T3 (da)
PT (1)	PT1124842E (da)
WO (1)	WO2000024762A1 (da)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB2362649A (en) *	2000-05-25	2001-11-28	Univerzita Palackeho V Olomouc	Triterpenoid derivatives
EP1292562A1 (en) *	2000-05-23	2003-03-19	Univerzita palackeho V Olomouci	Triterpenoid derivatives
GB0012528D0 (en)	2000-05-23	2000-07-12	Univ Palackeho	Triterpenoid derivatives
AU2001294959A1 (en) *	2000-09-29	2002-04-08	Robert M. Carlson	Triterpenes having antibacterial activity
AU2001294953A1 (en) *	2000-09-29	2002-04-08	Regents Of The University Of Minnesota	Triterpenes having fungicidal activity against yeast
US6951847B2 (en)	2000-09-29	2005-10-04	Regents Of The University Of Minnesota	Methods of treating fungal infections using lupeol
US7488722B2 (en) *	2001-05-11	2009-02-10	University Of Ottawa	Anxiolytic Marcgraviaceae compositions containing betulinic acid, betulinic acid derivatives, and methods
JPWO2003057224A1 (ja) *	2001-12-28	2005-08-25	日清オイリオグループ株式会社	アポトーシス誘導剤
US7041309B2 (en) *	2002-06-13	2006-05-09	Neuropro Technologies, Inc.	Spinal fusion using an HMG-CoA reductase inhibitor
SI1594885T1 (sl)	2003-02-11	2009-06-30	Novelix Pharmaceuticals Inc	Zdravilo za inhibiranje rasti tumorjev
US7026305B2 (en) *	2003-04-14	2006-04-11	Meharry Medical College	Anti-HIV agents with dual sites of action
WO2005112929A2 (en) *	2004-05-20	2005-12-01	Cornell Research Foundation, Inc.	Anti-hiv-1 activity of betulinol derivatives
US7282521B2 (en) *	2004-05-24	2007-10-16	University Of North Carolina At Chapel Hill	Anti-retroviral moronic acid derivatives
CA2595749A1 (en) *	2005-01-27	2006-08-03	Research Development Foundation	Combination therapy with triterpenoid compounds and proteasome inhibitors
EP1996205A2 (en) *	2006-03-23	2008-12-03	Advanced Life Sciences Inc.	Synthetic pentacyclic triterpenoids and derivatives of betulinic acid and betulin
CA2586614A1 (en) *	2006-10-27	2008-04-27	Universite Du Quebec A Chicoutimi	Triterpenes derivatives and uses thereof as antitumor agents or anti-inflammatory agents
RU2317996C1 (ru) *	2006-10-30	2008-02-27	Институт нефтехимии и катализа РАН	N'-{n-[3-оксо-лупан-28-оил]-9-аминононаноил}-3-амино-3-фенил-пропионовая кислота и ее соли как противовирусные и иммуностимулирующие агенты
CZ200851A3 (cs) *	2008-01-30	2009-10-21	Institut Of Organic Chemistry, Polish Academy Of Sciences	Sacharidové deriváty lupanu, jejich použití a farmaceutické prípravky obsahující tyto deriváty
JOP20190083A1 (ar)	2008-06-04	2017-06-16	Amgen Inc	بولي ببتيدات اندماجية طافرة لـfgf21 واستخداماتها
EP2340257A4 (en) *	2008-09-10	2012-09-26	Univ Quebec A Chicoutimi	BIDESMOSIDIC BETULIN AND BETULINIC ACID DERIVATIVES AND THEIR USE AS ANTITUMOROUS SUBSTANCES
KR101651703B1 (ko)	2008-10-10	2016-08-26	암젠 인크	Ｆｇｆ21 돌연변이체 및 이의 용도
US8778990B2 (en) *	2008-11-04	2014-07-15	Trustees Of Dartmouth College	Betulinic acid derivatives and methods of use thereof
CZ301318B6 (cs) *	2008-11-13	2010-01-13	Univerzita Palackého v Olomouci	2-Deoxyglykosidy triterpenoidu, zpusob jejich prípravy a jejich použití jako lécivo
CN102668347B (zh) *	2009-12-23	2015-12-02	马维尔国际贸易有限公司	启动电源
US8742735B2 (en)	2011-05-16	2014-06-03	Marvell World Trade Ltd.	High-voltage startup circuit
CN103534915B (zh)	2011-05-16	2016-08-17	马维尔国际贸易有限公司	高压启动电路
RU2468031C1 (ru) *	2011-11-02	2012-11-27	Учреждение Российской академии наук Институт химии и химической технологии Сибирского отделения РАН (ИХХТ СО РАН)	Способ получения 3,28-дисульфата бетулина
RU2477285C1 (ru) *	2012-03-23	2013-03-10	Федеральное Государственное Бюджетное Учреждение Науки Институт Химии И Химической Технологии Сибирского Отделения Российской Академии Наук (Иххт Со Ран)	Способ получения 3-ацетата-28-сульфата бетулина
CN103768078B (zh)	2012-10-22	2019-02-05	北京大学	三萜衍生物及其抗流感用途
CN104910239B (zh) *	2014-03-14	2018-12-07	中国科学院上海药物研究所	五环三萜类化合物及其制备方法、药物组合物和用途
CN114133424B (zh) *	2020-09-03	2023-07-18	沈阳药科大学	三萜类化合物及其制备方法和应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5962527A (en) *	1995-03-21	1999-10-05	The Board Of Trustees Of The University Of Illinois	Method and composition for treating cancers
US5869535A (en)	1995-03-21	1999-02-09	The Board Of Trustees Of The University Of Illinois	Method and composition for selectively inhibiting melanoma
US5658947A (en)	1995-03-21	1997-08-19	Board Of Trustees Of The University Of Illinois	Method and composition for selectively inhibiting melanoma using betalinic acid
KR100205045B1 (ko)	1996-12-05	1999-06-15	김송배	신규한 트리테르펜 글리코사이드 화합물, 그의 제조방법 및 그를 함유하는 항암제 조성물

1998
- 1998-10-28 US US09/182,588 patent/US6369109B1/en not_active Expired - Lifetime
1999
- 1999-10-28 ES ES99955899T patent/ES2201800T3/es not_active Expired - Lifetime
- 1999-10-28 EP EP99955899A patent/EP1124842B1/en not_active Expired - Lifetime
- 1999-10-28 AU AU12669/00A patent/AU1266900A/en not_active Abandoned
- 1999-10-28 WO PCT/EP1999/008196 patent/WO2000024762A1/en active IP Right Grant
- 1999-10-28 DE DE69908397T patent/DE69908397T2/de not_active Expired - Lifetime
- 1999-10-28 AT AT99955899T patent/ATE241641T1/de not_active IP Right Cessation
- 1999-10-28 PT PT99955899T patent/PT1124842E/pt unknown
- 1999-10-28 DK DK99955899T patent/DK1124842T3/da active

Also Published As

Publication number	Publication date
AU1266900A (en)	2000-05-15
WO2000024762A1 (en)	2000-05-04
EP1124842A1 (en)	2001-08-22
EP1124842B1 (en)	2003-05-28
DE69908397D1 (de)	2003-07-03
PT1124842E (pt)	2003-10-31
ES2201800T3 (es)	2004-03-16
US6369109B1 (en)	2002-04-09
DE69908397T2 (de)	2004-04-01
ATE241641T1 (de)	2003-06-15

Publication	Publication Date	Title
DK1124842T3 (da)	2003-09-22	Betulinsyrederivater anvendelige til behandling af neuroektodermale tumorer
DE60118003D1 (de)	2006-05-11	Harnstoffderivate und ihre verwendung
DE69830504D1 (de)	2005-07-14	Antithrombotische mitteln
EA200300293A1 (ru)	2003-08-28	Противовоспалительные конденсированные пирролокарбазолы
DE60035496D1 (de)	2007-08-23	Indolinderivate als progesteron antagonisten
ATE306261T1 (de)	2005-10-15	Antithrombosemittel
PT896533E (pt)	2004-02-27	Pentafluorobenzenosulfonamidas e analogos
ATE309237T1 (de)	2005-11-15	Aromatische heterozyklische verbindungen als antientzündungwirkstoffe
BG66084B1 (bg)	2011-03-31	Циклопентаноиндоли, състави,съдържащи такива съединения и използването им
ATE263157T1 (de)	2004-04-15	Nematizide trifluorbutene
MX9702865A (es)	1998-05-31	Agentes estrogenicos.
DK0939627T3 (da)	2003-10-13	Pentaflourbenzensulfonamider og analoger
ATE277929T1 (de)	2004-10-15	Immunsuppressive wirkungen von pteridinderivaten
ES2243579T3 (es)	2005-12-01	Derivados de pirazolopirideno.
EA200300716A1 (ru)	2003-12-25	Гетероциклилалкилиндольные или -азаиндольные соединения в качестве лиганд 5-гидрокситриптамина-6
DE60141636D1 (de)	2010-05-06	Phospholipidderivate von valproinsäure und ihre kombinationen
SE9804212D0 (sv)	1998-12-04	Compounds
SE9801494D0 (sv)	1998-04-28	Novel use
UY26426A1 (es)	2001-05-31	Nuevos compuestos
AP9801202A0 (en)	1999-08-26	Atropisomers of 3-heteroaryl-4(3H)-quinazolinones.
BR0212899A (pt)	2004-11-03	Compostos orgânicos
ATE266029T1 (de)	2004-05-15	Substituierte pyrrolobenzimidazolderivate zur entzündungshemmung
SE9604582D0 (sv)	1996-12-13	Novel compounds
TR199900523T2 (xx)	1999-05-21	Vir�s k�kenli hastal�klar�n tedavisi i�in farmas�tik bile�imler.
DK0937057T3 (da)	2003-05-05	Hidtil ukendte (-)-enantiomerer af cis-3,4-chromanderivater anvendelige i forebyggelse eller behandling af østrogenrelaterede sygdomme eller syndromer